Sign in

Covid-19: India-specific clinical score may predict risk

Among the risk factors that have been seen in Covid patients in India that likely led to the disease turning severe is more than one co-morbid condition such as diabetes and hypertension, chronic kidney disease and obesity.

Updated on: Jun 13, 2020, 05:12:07 IST
Hindustan Times, New Delhi | By
Share
Share via
  • facebook
  • twitter
  • linkedin
  • whatsapp
Copy link
  • copy link

Some members of the national task force on Covid-related matters have proposed an India-specific clinical score to identify people with coronavirus who are at a higher risk of developing severe disease or dying, which will help in picking up warning signs early and saving lives.

A  police personnel walks through a disinfection tunnel in Parliament Street Police station, New Delhi on Friday. (Sanchit Khanna/HT PHOTO)
A police personnel walks through a disinfection tunnel in Parliament Street Police station, New Delhi on Friday. (Sanchit Khanna/HT PHOTO)

While doctors have been using their clinical acumen to determine which patient could turn serious, the national guidelines will be standardised, looking at the overall evidence generated from the country.

“Some of us have been asking for analysis of India data and surveys to develop our own clinical score. It will require a set protocol that the task force is in the process of forming. However, no final decision has been taken on it yet,” said a member of the task force, who did not wish to be identified.

Among the risk factors that have been seen in Covid patients in India that likely led to the disease turning severe is more than one co-morbid condition such as diabetes and hypertension, chronic kidney disease and obesity.

“This is what is being usually seen but there could be other conditions that are specific to our patients. Hence, more evidence needs to be looked at comprehensively from hospitals across India to zero in on all those conditions that lead to a higher risk of Covid patients developing serious illnesses and not recovering as well. This will help further improve our case fatality rate,” said another member, requesting anonymity.

“CDC has also come out with a list of high-risk conditions among Covid patients, and it makes sense for India also to come up with a list of our own, based on how our patients behave,” the member added.

The US CDC (United States Centre for Disease Control) has enlisted 11 conditions that can lead to severe Covid disease.

The conditions are asthma, chronic kidney disease with dialysis, chronic lung disease, diabetes, haemoglobin disorders, immunocompromised condition, liver disease, people aged 65 years and older, people in nursing homes and long-term care facilities, serious heart conditions, and severe obesity.

A study published in JAMA network last month also endorsed creating a clinical risk score to “help identify patients with Covid-19 who may subsequently develop critical illness.”

Experts say it will also help in rationalising resources now that cases are rising in India.

“With the number of patients rising, this is also a way of rationalising how to use the medical resources in the best possible way, as people shouldn’t be occupying beds unnecessarily. Those who need it must get it,” said Dr GC Khilnani, former head, pulmonology department, All India Institute of Medical Sciences, Delhi.

The clinical score, he says, will also help doctors in taking note of patients with non-specific symptoms.

“Not everyone is landing with cough, or breathlessness, some are also coming with loss of smell or diarrhoea, so if there is a set list that doctors can refer to then it will improve patient selection at the time of triage, especially in smaller towns or remote areas,” he added.

  • Rhythma Kaul
    ABOUT THE AUTHOR
    Rhythma Kaul

    Rhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.Read More